We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 625 results
  1. B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1

    Immunotherapy exhibited potential effects for advanced hepatocellular carcinoma, unfortunately, the clinical benefits are often countered by cancer...

    Jiatao Li, Juan Feng, ... Cheng Qian in npj Precision Oncology
    Article Open access 01 July 2024
  2. Combination of MRI-based prediction and CRISPR/Cas12a-based detection for IDH genoty** in glioma

    Early identification of IDH mutation status is of great significance in clinical therapeutic decision-making in the treatment of glioma. We...

    Donghu Yu, Qisheng Zhong, ... Zhiqiang Li in npj Precision Oncology
    Article Open access 01 July 2024
  3. CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis

    Malignant pleural effusion (MPE) is a common occurrence in advanced cancer and is often linked with a poor prognosis. Eosinophils were reported to...

    Min Zhang, Lixia **a, ... Huahao Shen in npj Precision Oncology
    Article Open access 29 June 2024
  4. A fully automated and explainable algorithm for predicting malignant transformation in oral epithelial dysplasia

    Oral epithelial dysplasia (OED) is a premalignant histopathological diagnosis given to lesions of the oral cavity. Its grading suffers from...

    Adam J. Shephard, Raja Muhammad Saad Bashir, ... Nasir M. Rajpoot in npj Precision Oncology
    Article Open access 28 June 2024
  5. Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria

    Less than 15–20% of patients who meet the criteria for hereditary breast and ovarian cancer (HBOC) carry pathogenic coding genetic mutations,...

    Miguel Ruiz-De La Cruz, Héctor Martínez-Gregorio, ... Felipe Vaca-Paniagua in npj Precision Oncology
    Article Open access 19 June 2024
  6. Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome

    We conducted spatial immune tumor microenvironment (iTME) profiling using formalin-fixed paraffin-embedded (FFPE) samples of 25 KRAS -mutated...

    Dan Zhao, Haiqing Li, ... Ravi Salgia in npj Precision Oncology
    Article Open access 19 June 2024
  7. AI powered quantification of nuclear morphology in cancers enables prediction of genome instability and prognosis

    While alterations in nucleus size, shape, and color are ubiquitous in cancer, comprehensive quantification of nuclear morphology across a whole-slide...

    John Abel, Suyog Jain, ... Amaro Taylor-Weiner in npj Precision Oncology
    Article Open access 19 June 2024
  8. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule

    Prostate cancer (PCa) seldom metastasizes to the thyroid gland, and only a limited number of cases are documented in the literature. The application...

    Cameron Chalker, Burçak Yilmaz, ... Alexandra O. Sokolova in npj Precision Oncology
    Article Open access 15 June 2024
  9. NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

    Neurofibromatosis type 2 ( NF2 ) is a tumor suppressor gene implicated in various tumors, including mesothelioma, schwannomas, and meningioma. As a...

    Duo Xu, Shiyuan Yin, Yongqian Shu in npj Precision Oncology
    Article Open access 15 June 2024
  10. Artificial intelligence-based real-time histopathology of gastric cancer using confocal laser endomicroscopy

    There has been a persistent demand for an innovative modality in real-time histologic imaging, distinct from the conventional frozen section...

    Haeyon Cho, Damin Moon, ... Seokhwi Kim in npj Precision Oncology
    Article Open access 14 June 2024
  11. Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma

    Oral squamous cell carcinoma (OSCC) biomarker studies rarely employ multi-omic biomarker strategies and pertinent clinicopathologic characteristics...

    Chi T. Viet, Kesava R. Asam, ... Bradley E. Aouizerat in npj Precision Oncology
    Article Open access 08 June 2024
  12. Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis

    Our objective was to capture subgroups of soft-tissue sarcoma (STS) using handcraft and deep radiomics approaches to understand their relationship...

    Amandine Crombé, Carlo Lucchesi, ... Antoine Italiano in npj Precision Oncology
    Article Open access 07 June 2024
  13. Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer

    Chemotherapy such as cisplatin is widely used to treat ovarian cancer either before or after surgical debulking. However, cancer relapse due to...

    Anjali Geethadevi, Zhiqiang Ku, ... Pradeep Chaluvally-Raghavan in npj Precision Oncology
    Article Open access 05 June 2024
  14. Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs

    Metastatic cancer remains incurable as patients eventually loose sensitivity to targeted therapies and chemotherapies, further leading to poor...

    Amina Jamal Laham, Raafat El-Awady, ... Jean-Jacques Lebrun in npj Precision Oncology
    Article Open access 05 June 2024
  15. PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC

    Therapies targeting the PD-1/PD-L1 pathway have transformed head and neck squamous cell carcinoma (HNSCC) treatment. However, predicting the response...

    Bar Kaufman, Tarek Taha, ... Salem Billan in npj Precision Oncology
    Article Open access 03 June 2024
  16. Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung

    Fetal adenocarcinoma of the lung (FLAC) is a rare form of lung adenocarcinoma and was divided into high-grade (H-FLAC) and low-grade (L-FLAC)...

    Li Sun, Wei Guo, ... Lin Lin in npj Precision Oncology
    Article Open access 03 June 2024
  17. A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors

    Cancer is the second most common cause of death in children aged 1–14 years in the United States, with 11,000 new cases and 1200 deaths annually....

    David N. Buckley, Ben Yi Tew, ... Bodour Salhia in npj Precision Oncology
    Article Open access 01 June 2024
  18. Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers

    Acquired resistance remains a major challenge for therapies targeting oncogene activated pathways. KRAS is the most frequently mutated oncogene in...

    Daniel P. Nussbaum, Colin A. Martz, ... Kris C. Wood in npj Precision Oncology
    Article Open access 31 May 2024
Did you find what you were looking for? Share feedback.